Immunological aspects of Epstein-Barr virus infection

Shouichi Ohga, Akihiko Nomura, Hidetoshi Takada, Toshiro Hara

Research output: Contribution to journalArticlepeer-review

75 Citations (Scopus)


Epstein-Barr virus (EBV) is a member of ubiquitous γ herpes viruses, which primarily induces acute infectious mononucleosis (IM) or subclinical infection in susceptible subjects. The host reactions account for the clinical manifestation of IM. This virus also contributes to the development of lymphoid or epithelial malignancies. The outgrowth of EBV-infected B-cells is first controlled by interferon (IFN)-γ and natural killer (NK) cells, and later by EBV-specific cytotoxic T-lymphocytes (CTL). To overcome the host responses and establish the persistent infection, EBV conducts the protean strategies of immune evasion. Several EBV genes modulate apoptotic signals and cytokine balances to persist B-cell infection without insulting the host. Uncontrolled lymphoproliferation occurs as EBV+ B-cell lymphoproliferative disease (LPD)/lymphoma in AIDS, posttransplant, or primary immunodeficiency diseases (PID). On the other hand, EBV+ T/NK cells are involved in EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH) or chronic active EBV infection (CAEBV) in children having no underlying immunodeficiencies, and at times lead to the clonal evolution of T/NK-cell LPD/lymphomas. Recent advance in molecular techniques has enabled us to analyze the clonality of EBV-infected lymphocytes and to quantify the gene expression of EBV and cytokines. Dominant autocrine loop of T helper (Th) 2 and Th1 may exert in EBV+ B-LPD and T-LPD, respectively. Intensive studies on the immunological interface between effector components and EBV+ target cells will provide more information on clarifying the pathogenesis of EBV-associated lymphoid malignancies, as well as on exploiting the therapeutic and preventive strategies for the formidable EBV-associated disease in childhood.

Original languageEnglish
Pages (from-to)203-215
Number of pages13
JournalCritical Reviews in Oncology/Hematology
Issue number3
Publication statusPublished - Dec 1 2002

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology


Dive into the research topics of 'Immunological aspects of Epstein-Barr virus infection'. Together they form a unique fingerprint.

Cite this